Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024

Stock Price vs Company Growth
1d
0.0%
1w
9.5%
1m
2.8%
3m
6.7%
6m
4.9%
1y
36.8%
all
18.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 930 0%
786
984
Company Overview

Sales
2,170 Cr
Growth: 29.1%
Profit after Tax
333 Cr
Growth: 16.2%
Mid Cap
19,678 Cr
P/E: 59.6x
Industry P/E: 29.7x
Fundamentals

Sales (Cr) ₹ 2,170
Growth 29.1%
EBITDA 28.2%
P/S 9.1x
Dividend 0.0%
P/E 59.6x
Book Value ₹ 112
PEG Ratio 2.0x
ROE 14.9%
P/B 8.3x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms.
Followers (1)